A recent study has revealed that Green tea may reduce the risk of developing prostate cancer.
Researchers headed by Nagi B. Kumar of the Moffitt Cancer Center established that a component found in decaffeinated green tea stopped "prostate cancer development in men who have premalignant lesions."
Prostate cancer is the second most common type of cancer in men. For the study, nearly 100 men were recruited. According to a report in Science 2.0, researchers wanted to see whether green tea catechins suppressed prostate cancer growth in men who had high-grade intraepithelial neoplasia (HGPIN) or atypical small acinar proliferation (ASAP).
Green tea capsules that had a mixture of catechins, mainly Epigallocatechin-3-gallate (EGCG ) were used by researchers at a dosage of 200 mgs twice a day.
The group that consumed capsules mainly containing EGCG was associated to the placebo tablet group for a period of one-year.
According to MedicalXpress, though the difference in the number of prostate cancers was not noteworthy, it was seen that "in men who only had HGPIN at the beginning of the trial, they observed a lower combined rate of ASAP and prostate cancer development with Polyophenon E."
The results of the study will be presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on June 1.